Workflow
NYO3活性铬平衡胶囊
icon
Search documents
降糖产品质量报告追踪:控糖卫已下架,厦门市场监管部门已立案
Xin Jing Bao· 2025-08-29 09:17
Core Viewpoint - The article highlights the swift action taken by the Xiamen Market Supervision Administration in response to reports of false advertising related to "imported" blood sugar control drinks, leading to the removal of certain products from the market and ongoing investigations into the involved companies [1][4][5]. Regulatory Response - The Xiamen Market Supervision Administration has initiated an investigation into the companies involved in the false advertising of blood sugar control products, specifically targeting the "Kongtangwei" and "Breorqy" brands [1][5]. - The regulatory body has mandated the removal of product links and is conducting further investigations to address the reported violations [1][5][6]. Market Impact - The article notes that the false claims made by these products, such as being "imported" and having extraordinary effects on blood sugar control, misled consumers and posed challenges to diabetes treatment [4][5]. - The cost of the "Kongtangwei" product is estimated to be less than 10 yuan, while it is sold for over 100 yuan, indicating significant markup based on misleading claims [4]. Ongoing Issues - Despite the removal of certain products, many others continue to be sold with unchanged promotional content, indicating a persistent issue with false advertising in the market [7][8]. - The article points out that various other products, including chromium supplements and herbal teas, also make unverified claims regarding their effectiveness in controlling blood sugar levels [5][8]. Recommendations for Improvement - Experts suggest that regulatory efforts need to be strengthened, particularly in enhancing the oversight of e-commerce platforms to prevent the sale of products with exaggerated claims [8][9]. - There is a call for improved collaboration among regulatory bodies across different regions to ensure comprehensive monitoring and enforcement against misleading advertising practices [8][9].
“血糖克星”三价铬真相调查:降糖功效科学性研究不足
Bei Ke Cai Jing· 2025-08-27 05:40
三价铬,一种被众多商家宣称为"血糖克星""天然口服胰素""诺贝尔级糖尿克星",可以帮助消费者"轻松退出糖友圈"的成分,成了收割高血糖人群、糖尿病 患者焦虑的神器。这类具有"攻克糖尿病"奇效的产品并非药品,而是一类添加三价铬的膳食营养补充剂。新京报记者调查发现,这类膳食营养补充剂多为跨 境购商品,包装上往往没有中文标识,如需了解具体成分、产品信息等,需咨询客服,或通过产品的详情页展示的简单信息。 内分泌医学专家及营养学专家提醒,三价铬降糖功效的科学性研究不足。此类产品宣传属于打擦边球,"天然口服胰岛素"系夸大宣传,替代口服降糖药二甲 双胍、胰岛素更是不可能。专家提示,切莫相信虚假夸大宣传,擅自停药延误病情。 宣称可"修复胰岛",多商家承诺无效退款 在购物平台,以"降糖"为关键词,可以搜出不少"三价铬"产品,以跨境购产品居多,价格从几十元到数百元不等。在这类"三价铬膳食营养补充剂"的宣传 中,无论是什么价位的产品,众多商家的套路基本一致。在产品详细页面,会提及糖尿病的危害、并发症等,同时与其他类型的降糖产品作对比,强调其他 产品的弊端,以突出其产品的无副作用、无依赖、疗效好。此外,"三步/四步直击源头"几乎也是每 ...